Advertisement

Topics

Advanced Cancer Therapeutics (ACT) Company Profile

22:17 EDT 22nd March 2019 | BioPortfolio

ACT is a for-profit private company dedicated to advancing novel therapeutics for the prevention and treatment of cancer. ACT has successfully established a unique and innovative business model with the University of Louisville’s James Graham Brown Cancer Center (Brown Cancer Center) whereby ACT is able to obtain exclusive worldwide licenses to novel cancer therapeutics discovered at Brown Cancer Center under preset business terms. ACT then fast-tracks these discoveries, including the selection process for partnership, commercialization and manufacture, to the pharmaceutical industry, and ultimately to the patients who need them. Led by Dr. Don Miller, the Brown Cancer Center employs over forty scientists focused on the discovery and advancement of breakthrough cancer therapeutics for patients suffering from cancer. www.advancedcancertherapeutics.com.


News Articles [4285 Associated News Articles listed on BioPortfolio]

Mirati Therapeutics joins Cancer Research UK's Stratified Medicine Programme

Mirati Therapeutics, Inc. is the latest partner of Cancer Research UK s Stratified Medicine Programme, bringing new investigational treatment options to eligible patients with advanced lung cancer, th...

Combination of two immunotherapies shows activity in non-small cell lung cancer patients

(ECCO-the European CanCer Organisation) A combination of two drugs, which prompt the body's immune system to identify and kill cancer cells, is a safe treatment for patients with advanced non-small ce...

BriaCell Announces Positive Phase IIa Proof of Concept Data in Advanced Breast Cancer; Initiates Combination Study

BriaCell Therapeutics Corp. (“BriaCell”, the “Company”) (TSXV:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is plea...

Difficult-to-treat bowel cancers respond in first study of new drug combination

(ECCO-the European CanCer Organisation) Early results from a phase I trial in a small group of patients with advanced cancer using two drugs (nivolumab and pixatimod) that stimulate the immune system ...

Lung Cancer Video Library Mandarin - Immunotherapy Combinations in Advanced Squamous Non Small Cell Lung Cancer

Lung Cancer Video Library MandarinJenny J. Li, MD, GRACE Guest Faculty Chinese Transcript-Chemotherapy_Immunotherapy Combinations in Advanced

Targeted drugs for advanced cancer move from specialist units to community setting

Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network (NCCN) centres in the US, are receiving innovative drugs matched to DNA mutations in their tumours. This achi...

Mirati Therapeutics joins Cancer Research UK’s lung cancer programme

Mirati Therapeutics has joined Cancer Research UK’s Stratified Medicine Programme, which aims to develop new treatment options for patients with...Read More... The post Mirati Therapeutics joins Can...

Lung Cancer Video Library Mandarin - Combinations of Immunotherapy Agents in Advanced NSCLC

Lung Cancer Video Library - MandarinJenny J. Li, MD, GRACE Guest Faculty Chinese Transcript-Combinations of Immunotherapy Agents in Advanced NSCLC Current Status

Drugs and Medications [224 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]

NA

Gemcitabine hydrochloride [bluepoint laboratories]

These highlights do not include all the information needed to use Gemcitabine for Injection safely and effectively. See full prescribing information for Gemcitabine for Injection. Gemcitabine for inje...

Gemcitabine [fresenius kabi usa, llc]

These highlights do not include all the information needed to use GEMCITABINE FOR INJECTION, USP safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION, USP. GEMCITABIN...

Gemcitabine [fresenius kabi usa, llc]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP. Gemcitabin...

Gemcitabine hydrochloride [gland pharma limited]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP.Gemcitabine...

PubMed Articles [7739 Associated PubMed Articles listed on BioPortfolio]

Palliative care: needs of advanced breast cancer patients.

Advanced breast cancer is characterized by many physical manifestations with the potential to undermine the quality of life (most related to the cancer and some to treatments), as well as substantial ...

KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer.

Treatment options for patients with advanced esophageal or esophagogastric junction (EGJ) cancer are limited. Current guidelines for first-line treatment of advanced esophageal or EGJ cancer recommend...

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro.

In recent times, co-delivery of therapeutics has emerged as a promising strategy for treating dreadful diseases such as cancer.

Case Report: Ketamine for Pain and Depression in Advanced Cancer.

Patients with advanced cancer often suffer from both severe pain and severe symptoms of depression. Use of traditional antidepressants is often limited by the short prognosis associated with advanced ...

Teaching Patients with Advanced Cancer to Self-Advocate: Development and Acceptability of the Strong Together™ Serious Game.

Serious games are a growing form of psychoeducation, although few studies have evaluated serious games for patients with advanced cancer. The purpose of this study was to develop and assess the initia...

Clinical Trials [14793 Associated Clinical Trials listed on BioPortfolio]

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumorsfor

T-1101 is a novel anti-cancer agent being developed by Taivex Therapeutics Corporation, and is being studied in a phase I dose escalation trial, protocol TAI-001. That trial's primary aim ...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

AZD9291 in Combination With Ascending Doses of Novel Therapeutics

The purpose of this study is to determine the safety, tolerability and preliminary anti-tumour activity of AZD9291 when given together with one of either MEDI4736, AZD6094 OR selumetinib i...

Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

This research study is for individuals who have advanced breast, colon, pancreatic, ovarian or bladder cancer. Celldex Therapeutics, Inc. is testing a form of immune therapy (vaccine) to s...

Companies [3472 Associated Companies listed on BioPortfolio]

Advanced Cancer Therapeutics (ACT)

ACT is a for-profit private company dedicated to advancing novel therapeutics for the prevention and treatment of cancer. ACT has successfully established a unique and innovative ...

OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals is pioneering the development of novel therapeutics that target a new class of solid tumor cells, known as "cancer stem cells". The company's technology is based on a recent di...

Sopherion Therapeutics, LLC

Sopherion Therapeutics, LLC is a privately-held biotechnology company based in Princeton, New Jersey. The Company is focused on developing novel anti-cancer therapies for patients suffering from adva...

Lava Therapeutics

Lava Therapeutics’ proprietary platform is focused on developing next generation γδ T cell engaging bispecific antibodies to treat cancer. Our first-in-class immuno-onc...

Cancer Therapeutics, Inc.TM

Founded in 1991, Cancer Therapeutics, Inc.TM (CTI) is a biotherapy company that is a leader in activated cell technology for cancer therapy. CTI's laboratory offers access to technologies grouped unde...

More Information about "Advanced Cancer Therapeutics (ACT)" on BioPortfolio

We have published hundreds of Advanced Cancer Therapeutics (ACT) news stories on BioPortfolio along with dozens of Advanced Cancer Therapeutics (ACT) Clinical Trials and PubMed Articles about Advanced Cancer Therapeutics (ACT) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Cancer Therapeutics (ACT) Companies in our database. You can also find out about relevant Advanced Cancer Therapeutics (ACT) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record